MedTrace Logo

CanRestoreFunction Cancer-related Fatigue ( CRF )

NCT05868187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2024-12-09

No results posted yet for this study

Summary

The goal of this randomized control trial is to determine if participating in an 8-week online cancer-related fatigue management intervention consisting of individualized exercise program, one-on-one goal setting and action plan development and interactive educational module will significantly reduce the perception of cancer-related fatigue, improve the quality of life, improve perceived cognition, and perceived function of breast cancer compared to a wait-list control group. The aim the project is to determine if an online cancerrelated fatigue management program is associated with 1. A decrease in cancer-related fatigue. 2. An improved perception of their ability and satisfaction in completing important activities 3. Greater quality of life. 4. Improved mobility 5. Improved perceived cognition

Conditions

  • Breast Neoplasm

Interventions

BEHAVIORAL

Exercise, Problem-Solving Session and Education

Complete assigned exercises three times a week Complete Action plan co-developed Complete part or all of one of the four interactive educational modules

Sponsors & Collaborators

  • University of Dayton

    collaborator OTHER

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Anne Fleischer, Ph.D · University of Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-08-01
Completion
2024-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05868187 on ClinicalTrials.gov